Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus

Abbas, 2003 An, 2006, Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors, Mol. Ther., 14, 494, 10.1016/j.ymthe.2006.05.015 Bachrach, 1968, Foot-and-mouth disease, Annu. Rev. Microbiol., 22, 201, 10.1146/annurev.mi.22.100168.001221 Carrillo, 2005, Comparative genomics of foot-and-mouth disease virus, J. Virol., 79, 6487, 10.1128/JVI.79.10.6487-6504.2005 Chen, 2006, Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo, J. Virol., 80, 3559, 10.1128/JVI.80.7.3559-3566.2006 Chen, 2004, RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice, J. Virol., 78, 6900, 10.1128/JVI.78.13.6900-6907.2004 Chen, 2008, siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection, J. Drug Target, 16, 140, 10.1080/10611860701878750 Chinsangaram, 2001, Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase, J. Virol., 75, 5498, 10.1128/JVI.75.12.5498-5503.2001 Darcan-Nicolaisen, 2009, Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice, J. Immunol., 182, 7501, 10.4049/jimmunol.0713433 de los Santos, 2005, The leader protease of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response, J. Virol., 80, 1906, 10.1128/JVI.80.4.1906-1914.2006 Gitlin, 2005, Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches, J. Virol., 79, 1027, 10.1128/JVI.79.2.1027-1035.2005 Gonzalez, 2005, Amplification of RNAi – targeting HLA mRNAs, Mol. Ther., 11, 811, 10.1016/j.ymthe.2004.12.023 Grimm, 2007, Combinatorial RNAi: a winning strategy for the race against evolving targets?, Mol. Ther., 15, 878, 10.1038/sj.mt.6300116 Grimm, 2006, Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways, Nature, 441, 537, 10.1038/nature04791 Hall, 1999, Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT, Nucleic Acids Symp. Ser., 41, 95 Hamasaki, 2003, Short interfering RNA-directed inhibition of hepatitis B virus replication, FEBS Lett., 543, 51, 10.1016/S0014-5793(03)00400-9 Jacque, 2002, Modulation of HIV-1 replication by RNA interference, Nature, 418, 435, 10.1038/nature00896 Kahana, 2004, Inhibition of foot-and-mouth disease virus replication by small interfering RNA, J. Gen. Virol., 85, 3213, 10.1099/vir.0.80133-0 Kim, 2008, Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo, Antiviral Res., 80, 178, 10.1016/j.antiviral.2008.06.001 Knowles, 2003, Molecular epidemiology of foot-and-mouth disease virus, Virus Res., 91, 65, 10.1016/S0168-1702(02)00260-5 Lee, 2004, Control of HIV-1 replication by RNA interference, Virus Res., 102, 53, 10.1016/j.virusres.2004.01.015 Lo, 2007, Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters, Gene Ther., 14, 1503, 10.1038/sj.gt.3303011 Mäkinen, 2006, Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain, J. Gene Med., 8, 433, 10.1002/jgm.860 O’Brien, 2007, Inhibition of multiple strains of Venezuelan equine encephalitis virus by a pool of four short interfering RNAs, Antiviral Res., 75, 20, 10.1016/j.antiviral.2006.11.007 Pereira, 1981 Persengiev, 2004, Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs), RNA, 10, 12, 10.1261/rna5160904 Pusch, 2003, Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA, Nucleic Acids Res., 31, 6444, 10.1093/nar/gkg876 Reed, 1938, A simple method of estimating fifty percent end points, Am. J. Hygiene, 27, 493 Ren, 2007, The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains, Antivir. Ther., 12, 865, 10.1177/135965350701200607 Ryman, 2000, Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism, J. Virol., 74, 3366, 10.1128/JVI.74.7.3366-3378.2000 Sabariegos, 2006, Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs, J. Virol., 80, 571, 10.1128/JVI.80.2.571-577.2006 Saulnier, 2006, Complete cure of persistent virus infections by antiviral siRNAs, Mol. Ther., 13, 142, 10.1016/j.ymthe.2005.07.697 Song, 2008, Multiple shRNA expressing vector enhances efficiency of gene silencing, BMB Rep., 41, 358, 10.5483/BMBRep.2008.41.5.358 ter Brake, 2006, Silencing of HIV-1 with RNA interference: a multiple shRNA approach, Mol. Ther., 14, 883, 10.1016/j.ymthe.2006.07.007 ter Brake, 2008, Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition, Mol. Ther., 16, 557, 10.1038/sj.mt.6300382 Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Res., 22, 4673, 10.1093/nar/22.22.4673 Wu, 2007, Simultaneously inhibition of HIV and HBV replication through a dual small interfering RNA expression system, Antiviral Res., 74, 142, 10.1016/j.antiviral.2006.11.004 Wu, 2005, Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatment, Virus Res., 112, 100, 10.1016/j.virusres.2005.04.001